Here is What Hedge Funds Think About Targacept, Inc. (TRGT): ZIOPHARM Oncology Inc. (ZIOP), Chelsea Therapeutics International Ltd. (CHTP)

Targacept, Inc. (NASDAQ:TRGT) investors should pay attention to a decrease in support from the world’s most elite money managers lately.

David Shaw

According to most market participants, hedge funds are seen as slow, old investment vehicles of yesteryear. While there are over 8000 funds with their doors open today, we choose to focus on the moguls of this club, around 450 funds. It is widely believed that this group has its hands on the majority of the smart money’s total capital, and by tracking their highest performing stock picks, we have identified a few investment strategies that have historically beaten the S&P 500 index. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 25 percentage points in 6.5 month (see all of our picks from August).

Equally as key, positive insider trading sentiment is a second way to parse down the world of equities. Just as you’d expect, there are a variety of stimuli for an executive to sell shares of his or her company, but only one, very simple reason why they would initiate a purchase. Various empirical studies have demonstrated the impressive potential of this tactic if shareholders understand where to look (learn more here).

Consequently, it’s important to take a glance at the recent action encompassing Targacept, Inc. (NASDAQ:TRGT).

Hedge fund activity in Targacept, Inc. (NASDAQ:TRGT)

At year’s end, a total of 10 of the hedge funds we track held long positions in this stock, a change of -9% from one quarter earlier. With hedge funds’ capital changing hands, there exists a few notable hedge fund managers who were boosting their stakes considerably.

When looking at the hedgies we track, D E Shaw, managed by D. E. Shaw, holds the biggest position in Targacept, Inc. (NASDAQ:TRGT). D E Shaw has a $2 million position in the stock, comprising 0% of its 13F portfolio. Coming in second is Renaissance Technologies, managed by Jim Simons, which held a $1 million position; the fund has 0% of its 13F portfolio invested in the stock. Other hedgies that hold long positions include Sander Gerber’s Hudson Bay Capital Management, Jacob Gottlieb’s Visium Asset Management and Israel Englander’s Millennium Management.

Since Targacept, Inc. (NASDAQ:TRGT) has witnessed a declination in interest from hedge fund managers, we can see that there were a few money managers that slashed their entire stakes at the end of the year. It’s worth mentioning that Jean-Marie Eveillard’s First Eagle Investment Management sold off the largest investment of the 450+ funds we monitor, comprising an estimated $3 million in stock., and Mike Vranos of Ellington was right behind this move, as the fund sold off about $0 million worth. These transactions are important to note, as aggregate hedge fund interest was cut by 1 funds at the end of the year.

What do corporate executives and insiders think about Targacept, Inc. (NASDAQ:TRGT)?

Insider buying is most useful when the company in focus has seen transactions within the past 180 days. Over the last 180-day time frame, Targacept, Inc. (NASDAQ:TRGT) has experienced 3 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Targacept, Inc. (NASDAQ:TRGT). These stocks are ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Geron Corporation (NASDAQ:GERN), ImmunoCellular Therapeutics Ltd (NYSEAMEX:IMUC), and Pacific Biosciences of California (NASDAQ:PACB). This group of stocks belong to the biotechnology industry and their market caps resemble TRGT’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 6 1 0
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) 3 0 1
Geron Corporation (NASDAQ:GERN) 7 0 1
ImmunoCellular Therapeutics Ltd (NYSEAMEX:IMUC) 2 0 1
Pacific Biosciences of California (NASDAQ:PACB) 7 1 0

With the returns demonstrated by the aforementioned studies, retail investors must always pay attention to hedge fund and insider trading activity, and Targacept, Inc. (NASDAQ:TRGT) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 37% between September 2012 and March 2013 versus 12.9% for the S&P 500 index. Try it now by clicking the link above.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!